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ABSTRACT
Streptococcus pneumoniae septic arthritis is an uncommon infection. The classic clinical picture is that of
concomitant pulmonary and ⁄ or meningeal and joint infections in the presence of predisposing local and
systemic factors. Initial laboratory tests are usually inconclusive, and joint aspiration is required for a
definitive diagnosis. Treatment options include antibiotic therapy (usually with penicillin) combined
with closed or open joint drainage. Increasing reports of infections involving penicillin-resistant strains
are a concern. The prognosis is usually favourable, but early recognition and aggressive management
are essential to reduce the likelihood of significant joint injury.
Keywords Arthritis, pneumococcal arthritis, septic arthritis, Streptococcus pneumoniae
Clin Microbiol Infect 2004; 10: 1037–1039
Non-gonococcal bacterial infections are the most
serious infections of adult joints, usually affecting
large joints [1]. Most (80–90%) of these infections
are monoarticular, but polyarticular involvement
is seen in conditions such as rheumatoid arthritis
[2]. Staphylococcus aureus and non-group A
b-haemolytic streptococci are the Gram-positive
organisms involved most frequently [3]. The first
reported case of Streptococcus pneumoniae septic
arthritis was in 1888 [4], with 285 cases being
reported in the scientific literature between 1888
and 1970 [4]. More recent series have found rates
of 3–5% among all patients with septic arthritis
[3], while rates of 8–10% have been reported from
the UK and New Zealand [5–7]. The joint affected
most frequently is the knee, followed by the
shoulder, the elbow and multiple joints [4,6–9].
A recent review of S. pneumoniae spinal infection
in the UK included a total of 28 cases from 1970 to
1997 [10]. S. pneumoniae septic arthritis of the hip
is also reported occasionally [6–9].
Middle-aged and elderly adults seem to be
more vulnerable to S. pneumoniae septic arthritis
[6–8,10]. Higher rates in male adults have been
reported [4,5,10], but this finding has not been
confirmed by others [6,8,9]. Most patients with
S. pneumoniae septic arthritis have one or more
underlying articular or non-articular illnesses and
host factors predisposing to joint infection,
including preceding upper respiratory tract infec-
tion, alcohol abuse, trauma, diabetes mellitus,
rheumatoid arthritis, osteoarthritis, corticosteroid
therapy, multiple myeloma and other malignan-
cies, and cardiovascular disease and other colla-
gen vascular diseases [4,6–10]. Patients with
rheumatoid arthritis are predisposed to polyartic-
ular septic arthritis of any aetiology (up to 25%).
Four or more joints may be involved [7]. It has
been suggested that S. pneumoniae may tend to
involve multiple joints irrespective of the presence
of rheumatoid arthritis [11]. Other risk factors
noted less frequently include gout, splenectomy,
HIV infection [7,12–14] and hip osteonecrosis
(I. Baraboutis, unpublished data). Surprisingly,
S. pneumoniae septic arthritis is an uncommon
complication in adult patients with sickle cell
disease [9]. Rarely, S. pneumoniae septic arthritis
involves prosthetic joints, mostly knees and hips
[15–17].
S. pneumoniae septic arthritis has been associ-
ated with pneumococcal pneumonia in 70–75%
of patients from older series and 29–36% of
patients in more recent series [4,6–8]. Other
primary foci include the meninges, endocar-
dium, pleural space, or combinations of these
[6–8,10]. Absence of concomitant infection else-
where is found in 10–50% of patients [6–8].
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Conversely, S. pneumoniae septic arthritis is an
infrequent complication of pneumococcal pneu-
monia (c. 0.3%), even before the emergence of
antibiotic resistance [9].
The clinical presentation of patients with
S. pneumoniae septic arthritis may combine symp-
toms from the affected joint(s) and concomitant
pneumococcal infection elsewhere, usually pneu-
monia and ⁄ or meningitis. Joint symptoms may
appear before, at the same time or after the onset
of the primary infection [10]. The mean duration
of pain before diagnosis of spinal involvement is
5.5 weeks [10]. S. pneumoniae septic arthritis
involving other sites has a much faster onset,
usually 3–5 days [6], but the delay in diagnosis of
S. pneumoniae septic arthritis involving prosthetic
hips may be several months [16,17]. Fever of
> 38C upon admission is recorded in 45–65% of
cases [6,8,10], although a small series reported
fever in 83% and shaking chills in 42% of cases
[9]. Lack of febrile response is especially common
with spinal involvement [10,18]. Local symptoms
are usually intense, but there are no specific local
findings [4]. Advanced infection with joint
destruction and pus extension in the surround-
ings is rarely seen nowadays.
The peripheral white blood cell count is usu-
ally elevated with a left shift (mean of
> 11 · 109 cells ⁄L, including spine cases) [6,8–
10]. A low white blood cell count is indicative of
a poor prognosis. The erythrocyte sedimentation
rate is usually elevated (> 90 mm ⁄h in > 50% of
cases) [6,10]. Bacteraemia occurs in 70–90% of
patients who have blood cultures taken, and in
30–56% of patients with spinal involvement
[6,10]. Conversely, arthritic symptoms occurring
during or following pneumonia cannot be
ascribed safely to S. pneumoniae septic arthritis
without compatible joint fluid findings [4]. The
joint fluid is usually thick, yellow–brown and
purulent, but occasionally may be only slightly
turbid [4,8,9]. The joint fluid white blood cell
count may range from 7000 to > 100 000
cells ⁄mm3 [4,8,9]. Gram’s stain and culture of
fluid yields positive results in > 75% and 60–85%
of cases, respectively [6,8,9]. Serotyping has indi-
cated the involvement of multiple serotypes, most
of which are included in the 23-valent pneumo-
coccal vaccine [6,8]. Most isolates reported to date
have been susceptible to penicillin, although
reports of infections with moderately or even
highly resistant strains are a concern [19].
Imaging is not essential for the diagnosis of
S. pneumoniae septic arthritis, with the exception
of spinal involvement and the suspicion of an epi-
dural abscess, in which case magnetic resonance
imaging is indicated [10]. Radiographic findings
include those related to the underlying disease
and, additionally, soft tissue swelling or effusion,
joint destruction in neglected cases, adjacent
osteomyelitis and, rarely, periarticular calcifica-
tion [9,18].
Before the antibiotic era, treatment included
multiple aspirations or open drainage [9]. Subse-
quently, intravenous penicillin has been the pre-
ferred drug, with third-generation cephalosporins
and vancomycin being reasonable alternatives
[4,6–8,10]. There is no consensus on the duration
of intravenous therapy (usually for 3–4 weeks,
but 6–8 weeks for spinal infections) and the role
of subsequent oral therapy [7–10]. Intra-articular
antibiotics are not necessary [6]. Many cases of
S. pneumoniae septic arthritis have been treated
successfully with antimicrobial agents, together
with one or more closed-needle aspirations [6,8].
Some centres use routine surgical lavage, either
arthroscopic or open [6–8]. Surgical drainage may
be more important with hip involvement, especi-
ally in children and when the joint fluid is very
thick and loculated [4,9,20]. Early surgery is
advised for spinal S. pneumoniae septic arthritis
with significant spine instability and suspicion of
epidural abscess [10]. Several cases of S. pneumo-
niae septic arthritis involving prosthetic joints
have been managed adequately with long courses
of antibiotics and open drainage [6,8].
The prognosis for S. pneumoniae septic arthritis
was favourable even in the pre-antibiotic era.
With appropriate antibiotic therapy and surgical
intervention, residual morbidity is usually min-
imal [7–10]. The short-term prognosis depends
also on underlying host factors, accounting for the
long duration of hospitalisation and high mortal-
ity (up to 32%) in some series [6,7,9]. In a large
review, mortality was predicted only by positive
blood culture [8]. Most published reviews have
not provided data on previous pneumococcal
vaccination.
In summary, S. pneumoniae septic arthritis
remains an uncommon infection. However, it
should be considered in cases of concomitant
pulmonary and ⁄ or meningeal and joint infection,
especially in the presence of predisposing factors.
The prognosis is usually favourable. Neverthe-
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less, early recognition and aggressive manage-
ment are imperative to reduce the likelihood of
significant joint injury. Since experience with
antimicrobial agents other than penicillin is very
limited, and reports of infections involving peni-
cillin-resistant strains are increasing, improved
awareness of this syndrome is essential.
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